• Home
  • NEW DAY MEDICINE
  • 2 (88) 2026
  • 67 -2 (88) 2026 - Ruziyeva N.H., Tursunova M.B. - CLINICAL CASE OF OVARIAN PREMATURE DEPRECIATION SYNDROME IN A FERTILE WOMAN: OPPORTUNITIES OF AUXILIARY REPRODUCTIVE TECHNOLOGIES AND PREDICTION OF IVF WITHOUT DONOR CELLS

67 -2 (88) 2026 - Ruziyeva N.H., Tursunova M.B. - CLINICAL CASE OF OVARIAN PREMATURE DEPRECIATION SYNDROME IN A FERTILE WOMAN: OPPORTUNITIES OF AUXILIARY REPRODUCTIVE TECHNOLOGIES AND PREDICTION OF IVF WITHOUT DONOR CELLS

CLINICAL CASE OF OVARIAN PREMATURE DEPRECIATION SYNDROME IN A FERTILE WOMAN: OPPORTUNITIES OF AUXILIARY REPRODUCTIVE TECHNOLOGIES AND PREDICTION OF IVF WITHOUT DONOR CELLS

Ruziyeva N.H. - Tashkent State Medical University

Tursunova M.B. - Tashkent State Medical University

Resume

Premature ovarian insufficiency (POI) is a complex reproductive disorder characterized by early loss of ovarian function in women under 40 years of age and is often associated with infertility. Traditionally, assisted reproductive technologies using donor oocytes are considered the main treatment option. However, recent advances demonstrate that pregnancy using autologous oocytes may be possible in selected patients. This article presents a clinical case of infertility associated with POI and analyzes the potential of assisted reproductive technologies without donor cells, as well as prognostic factors influencing IVF outcomes. The results confirm that individualized treatment strategies may allow achieving pregnancy despite extremely low ovarian reserve.

Key words: premature ovarian failure syndrome, infertility, ovarian reserve, IVF, assisted reproductive technologies

First page

336

Last page

340

For citation:Ruziyeva N.H., Tursunova M.B. - CLINICAL CASE OF OVARIAN PREMATURE DEPRECIATION SYNDROME IN A FERTILE WOMAN: OPPORTUNITIES OF AUXILIARY REPRODUCTIVE TECHNOLOGIES AND PREDICTION OF IVF WITHOUT DONOR CELLS//New Day in Medicine 2(88)2026 336-340 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

  1. Nelson L.M. Primary ovarian insufficiency. N Engl J Med. 2009;360:606-614.
  2. De Vos M., Devroey P., Fauser B.C. Primary ovarian insufficiency. Lancet. Lancet 2010; 376: 911–21 Published Online August 12, 2010 DOI:10.1016/S0140-6736(10)60355-8
  3. Coulam C.B. Premature ovarian failure. Fertil Steril. Obstet. Gynecol. 1986;67:604,
  4. Европейское общество репродукции человека и эмбриологии (ESHRE) 2020.
  5. Practice Committee of ASRM 2020.
  6. Shelling A.N. Premature ovarian failure. Reproduction. 2010;140:633–641.
  7. Welt C.K. Pathogenesis and management of POI Oct 2025.
  8. Goswami D., Conway G.S. Premature ovarian failure. Hum Reprod Update. Human Reproduction Update, 2005;11(4):391-410.
  9. Check J.H. IVF in women with ovarian failure Clin Exp Obstet Gynecol 2002;29(1):11-4.
  10. Бурдули А.Г., Тетруашвили Н.К., Балмасова И.П., Донников А.Е., Крашенинникова Р.В., Калинина Е.А. Клинико-иммунологическая характеристика женщин с бесплодием и привычным выкидышем в анамнезе. Акушерство, Гинекология и Репродукция. 2025;19(6):836–848. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.697
  11. Сухих Г.Т. Бесплодие и ВРТ https://dx.doi.org/10.18565/aig.2021.7.74-80
  12. Корнеева И.Е. Овариальный резерв. https://doi.org/10.14341/probl13592
  13. La Marca A., Volpe A. AMH in ovarian reserve assessment. https://doi.org/10/3359/physioier.932076
  14. Silber S.J. Ovarian aging and IVF outcomes. https://doi.org/10.1007/s43032-023-01427-1

    file

    download